Medical Grand Rounds - Update on Post-COVID

Friday, December 3, 2021 | 12 p.m. - 1 p.m.

Presenter: Benjamin Abramoff, MD, MS, Attending Physician and Assistant Professor, Department of Physical Medicine and Rehabilitation; Director, Spinal Cord Injury Services; Director, PIRM Seating and Positioning Clinic; Founder, Post-COVID Assessment and Recovery Clinic, University of Pennsylvania-Perelman School of Medicine, Philadelphia, PA

At the conclusion of this activity, participants should be able to:

  1. Describe and understand the prevalence and manifestations of “Long COVID.”
  2. Acquire knowledge about the evaluation of individuals who have “Long COVID.”
  3. Describe the role of an interdisciplinary and rehabilitation team in supporting individuals’ recovery with “Long COVID.”
  4. Learn about the selected “Long COVID” symptom management. 
     
Date:  Friday, December 3, 2021
Time:  12 p.m.
Location: Microsoft Teams - E-mail Trish.Stern@Guthrie.org to be included

 

This program is intended for: Physicians, Advanced Practice Providers, Fellows, Residents, Medical and Nursing Students, and other Ancillary Healthcare Professionals.

Accreditation Statement
“The Guthrie Clinic is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicians.”

Designation Statement
“The Guthrie Clinic designates this live activity for a maximum of (1.0) AMA PRA Category I Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.”

Disclosure/Conflict of Interest Statement
“Faculty and all others who have the ability to control the content of continuing medical education activities sponsored by The Guthrie Clinic are expected to disclose to the audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s).” “The presenting faculty/planning committee for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.”